Spectrum VII Investment Managers' Fund, L.P.'s Form 4 filing
Definitive Healthcare Corp.DH · filed May 12, 2022
- Accession no.
- 0000899243-22-017778
- Filed
- May 12, 2022, 5:17 PM ET
- Trade date
- May 10-11, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $99.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Spectrum VII Investment Managers' Fund, L.P.CIK 0001626997 | Director, 10% Owner |
| Spectrum VII Co-Investment Fund, L.P.CIK 0001822087 | Director, 10% Owner |
| Spectrum Equity Associates VII, L.P.CIK 0001824228 | Director, 10% Owner |
| SEA VII Management, LLCCIK 0001824265 | Director, 10% Owner |
| SE VII DHC AIV Feeder, L.P.CIK 0001879377 | Director, 10% Owner |
| SE VII DHC Aiv, L.P.CIK 0001879386 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 10, 2022 | Class B Common Stock | JOtherDisposed | −2,717,042 | –F1,F2 | – | 24,091,844 | Indirect | |
| May 10, 2022 | Class A Common Stock | CConversionAcquired | +2,717,042 | –F1,F2 | – | 5,508,971 | Indirect | |
| May 10, 2022 | Class A Common Stock | JOtherDisposed | −2,993,760 | $0.00F4 | $0 | 2,515,211 | Indirect | |
| May 11, 2022 | Class A Common Stock | SSaleDisposed | −1,490 | $15.55F5 | −$23,169.5 | 2,513,721 | Indirect | |
| May 11, 2022 | Class A Common Stock | SSaleDisposed | −2,550 | $15.55F6 | −$39,652.5 | 2,511,171 | Indirect | |
| May 11, 2022 | Class A Common Stock | SSaleDisposed | −811 | $16.52F7 | −$13,397.72 | 2,510,360 | Indirect | |
| May 11, 2022 | Class A Common Stock | SSaleDisposed | −1,389 | $16.52F8 | −$22,946.28 | 2,508,971 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
See Exhibit 99.1 for the text of footnote (1).
Referenced by the price of 2 transactions in Table I and 1 transaction in Table II.
- F2
See Exhibit 99.1 for the text of footnote (2).
Referenced by the price of 2 transactions in Table I and 1 transaction in Table II.
- F4
See Exhibit 99.1 for the text of footnote (4).
Referenced by the price of 1 transaction in Table I.
- F5
See Exhibit 99.1 for the text of footnote (5).
Referenced by the price of 1 transaction in Table I.
- F6
See Exhibit 99.1 for the text of footnote (6).
Referenced by the price of 1 transaction in Table I.
- F7
See Exhibit 99.1 for the text of footnote (7).
Referenced by the price of 1 transaction in Table I.
- F8
See Exhibit 99.1 for the text of footnote (8).
Referenced by the price of 1 transaction in Table I.
Remarks
Christopher T. Mitchell, a Managing Director of Spectrum and Jeffrey C. Haywood, a Managing Director of Spectrum (together, the "Spectrum Directors"), each serve on the board of directors of the Issuer, and have been deputized to represent the Reporting Persons on the board of directors. By virtue of the Spectrum Directors' representation, for purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons may be deemed directors by deputization of the Issuer. The Spectrum Directors have filed separate Section 16 reports disclosing securities of the Issuer that they may be deemed to beneficially own for Section 16 purposes.